Kathryn Rae Wagner

Title: Kathryn Rae Wagner: Pioneering Advances in Muscular Dystrophy Research

Introduction

Kathryn Rae Wagner is an accomplished inventor based in Baltimore, MD, with a remarkable portfolio of four patents. Her contributions primarily focus on innovative solutions for muscular dystrophies, showcasing her commitment to advancing medical research and treatments.

Latest Patents

Among her notable inventions is the patent for a human iPSC-based drug testing platform designed specifically for muscular dystrophy. This method emphasizes the identification of compounds for treating muscular dystrophies using disease-relevant cells derived from patients. The compounds identified through these innovative methods hold significant promise for the effective treatment of muscular dystrophy.

Additionally, Kathryn has developed patents related to AAV capsids identified through in vivo library selection. This disclosure encompasses adeno-associated virus capsid proteins isolated from an in vivo library, as well as recombinant adeno-associated viruses (rAAVs) that incorporate these proteins. In various embodiments, these rAAVs and the associated compositions have potential applications for delivering transgenes to muscle tissue, further contributing to the advancement of gene therapy techniques.

Career Highlights

Kathryn has worked with prestigious institutions, including The Johns Hopkins University and the University of Massachusetts. Her role at these research institutions has enabled her to explore and develop novel therapeutic strategies that could substantially impact the treatment landscape for muscular dystrophies.

Collaborations

Throughout her career, Kathryn has collaborated with talented individuals including Miguel Sena Esteves and Sourav Roy Choudhury. These collaborations have been instrumental in fostering an environment of innovation and shared knowledge, driving her research endeavors forward.

Conclusion

Kathryn Rae Wagner exemplifies the spirit of innovation within the field of medical research. With her significant contributions to the understanding and treatment of muscular dystrophies, she stands as a beacon of hope for many. Her ongoing commitment to developing groundbreaking solutions highlights the critical role of inventors in shaping the future of healthcare.